Lateral Flow Assay Market by Product (Kit, Readers), Application (STI, Covid-19, Hep, TB, Cardiac marker, Pregnancy; Drug abuse, Vet Diaganostic, Food), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User - Global Forecast to 2029
The lateral flow assays market is valued at an estimated USD 10.8 billion in 2023 and is projected to reach USD 16.8 billion by 2029, at a CAGR of 7.6% during the forecast period. The rising of the lateral flow assay market is because of the high prevalence of infectious diseases in many countries, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices, However the timorousness amongst the doctors and patients to adapt the existing diagnostic procedures and the low accuracy of lateral flow assays are some of the factors which are restraining the market.
'The lateral flow readers segment accounted for the fastest growing share in the lateral flow assays market.'
The lateral flow readers is a part of the product segment in lateral flow assays market . Its large share can be attributed to as it enable the quantitative analysis of lateral flow strips in sandwich, competitive,as well as in the reverse-competitive test formats. The lateral flow readers measures the intensity of the test line to determine the. number of analytes present in the sample and yield an assay result that is entirely quantitative. These can also take several readings from a single device or one read from several devices, which is then automatically analyzed statistically to provide a consolidated number. Lateral Flow readers can quantify, precisely collect, and transfer data. They are also very sensitive.
'The urine sample accounted for the second largest segment in the lateral flow assays market.'
On the basis of the sample type , the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Urine samples accounted for the second largest market share in 2022. The increasing utilization of the urine samples in lateral flow tests for pregnancy, fertility testing, and drug of abuse testing are some of the factors which attribute to the growth of the segment.
'Asia Pacific market to witness the highest growth during the forecast period.'
During the forecast period, APAC is anticipated to grow at the fastest rate. The major factors are as a lot of manufacturers are significantly increasing their manufacturing especially in the Asia Pacific region, which is exhibiting a low-cost manufacturing advantages also the availability of a skilled workforce in these regions. The major factors that are restricting the growth of the market in this region is the lack of awareness about the advantages of near-patient testing products due to lack of reimbursements, challenges related to locational remoteness, and low literacy rates.
A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:
Research Coverage:
The market study covers the lateral flow assays market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by product, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall lateral flow assays market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
'The lateral flow readers segment accounted for the fastest growing share in the lateral flow assays market.'
The lateral flow readers is a part of the product segment in lateral flow assays market . Its large share can be attributed to as it enable the quantitative analysis of lateral flow strips in sandwich, competitive,as well as in the reverse-competitive test formats. The lateral flow readers measures the intensity of the test line to determine the. number of analytes present in the sample and yield an assay result that is entirely quantitative. These can also take several readings from a single device or one read from several devices, which is then automatically analyzed statistically to provide a consolidated number. Lateral Flow readers can quantify, precisely collect, and transfer data. They are also very sensitive.
'The urine sample accounted for the second largest segment in the lateral flow assays market.'
On the basis of the sample type , the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Urine samples accounted for the second largest market share in 2022. The increasing utilization of the urine samples in lateral flow tests for pregnancy, fertility testing, and drug of abuse testing are some of the factors which attribute to the growth of the segment.
'Asia Pacific market to witness the highest growth during the forecast period.'
During the forecast period, APAC is anticipated to grow at the fastest rate. The major factors are as a lot of manufacturers are significantly increasing their manufacturing especially in the Asia Pacific region, which is exhibiting a low-cost manufacturing advantages also the availability of a skilled workforce in these regions. The major factors that are restricting the growth of the market in this region is the lack of awareness about the advantages of near-patient testing products due to lack of reimbursements, challenges related to locational remoteness, and low literacy rates.
A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
- By Designation: C-level–45%, Director Level–25%, and Others–30%
- By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%
Research Coverage:
The market study covers the lateral flow assays market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by product, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall lateral flow assays market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
- Analysis of key drivers (High prevalence of infectious diseases, increasing of the geriatric population, Growing use of home-based lateral flow assays devices, Growing demand for point of care testing and need for rapid diagnostic testing for COVID-19), restraints (Inconsistent results of lateral flow analysis), opportunities (evolving application of lateral flow assays, rising demand for lateral flow assays in the food and beverage industries) and challenges limited reimbursements for lateral flow assay products and difficulty in procuring quality raw materials for the development of lateral flow assays tests) influencing the growth of the lateral flow assays market.
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the lateral flow assays market. The report analyzes this market by type of product, application, technique, sample, end-user, and region.
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the lateral flow assays market.
- Market Development: Comprehensive information on the lucrative emerging markets by type of product, application, sample, technique, end-user, and region.
- Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the lateral flow assays market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the lateral flow assays market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION
1.3.2 REGIONS COVERED
FIGURE 2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Breakdown of primaries
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
FIGURE 7 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2022)
FIGURE 8 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2022)
FIGURE 9 APPROACH 4: TOP-DOWN APPROACH
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2029): IMPACT ON MARKET GROWTH AND CAGR
FIGURE 11 CAGR PROJECTIONS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 12 DATA TRIANGULATION METHODOLOGY
2.4 KEY INDUSTRY INSIGHTS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
2.7 STUDY ASSUMPTIONS
2.8 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION)
FIGURE 14 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023 VS. 2029 (USD MILLION)
FIGURE 15 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
FIGURE 16 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023 VS. 2029 (USD MILLION)
FIGURE 17 LATERAL FLOW ASSAYS MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
FIGURE 18 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
FIGURE 19 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET
FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD
4.3 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY (2022)
FIGURE 21 CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
4.5 LATERAL FLOW ASSAYS MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES
FIGURE 23 EMERGING ECONOMIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 High prevalence of infectious diseases
TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021)
5.2.1.2 Rising geriatric population
FIGURE 25 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION)
FIGURE 26 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION)
5.2.1.3 Growing use of home-based lateral flow assay devices
5.2.1.4 Growing demand for POC testing
5.2.2 RESTRAINTS
5.2.2.1 Inconsistent results of lateral flow assay tests
5.2.3 OPPORTUNITIES
5.2.3.1 Evolving applications of lateral flow assays
TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
5.2.3.2 Rising demand for lateral flow assays in food & beverage industry
5.2.3.3 Emergence of Omicron COVID variant
TABLE 4 EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT
TABLE 5 EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE TO DETECT OMICRON
5.2.4 CHALLENGES
5.2.4.1 Limited reimbursements for lateral flow assay products
5.2.4.2 Difficulties in procuring quality raw materials to develop tests
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND, BY APPLICATION
TABLE 6 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY COMPANY AND APPLICATION, 2021–2023
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
TABLE 7 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 2022
5.5 ECOSYSTEM
TABLE 8 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS (2022)
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL & MEDIUM-SIZED COMPANIES
5.6.3 END USERS
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN LATERAL FLOW ASSAYS MARKET, 2013–2023
5.7.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS
FIGURE 29 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016–2022
5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016–2022
5.8 VALUE CHAIN ANALYSIS
FIGURE 31 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2022)
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS
5.9.2 ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
5.10 CASE STUDY ANALYSIS
5.10.1 CASE STUDY 1: QUIDEL LAUNCHES NEW TEST WITH BROADER DETECTION WINDOW
5.10.2 CASE STUDY 2: ABINGTON OFFERS HIGH-SENSITIVITY TESTS FOR GREATER QUALITY
5.10.3 CASE STUDY 3: SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY LANDSCAPE
5.11.1.1 North America
5.11.1.2 Europe
5.11.1.3 Asia
5.11.1.3.1 India
5.11.1.3.2 China
5.11.1.3.3 Japan
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.1 North America
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.2 Europe
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.3 Asia Pacific
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.4 Latin America
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.5 Rest of the world
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 14 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 ADJACENT MARKET ANALYSIS
FIGURE 32 LATERAL FLOW ASSAYS: OVERVIEW OF ADJACENT MARKETS
5.14 KEY CONFERENCES AND EVENTS, 2023–2024
TABLE 15 LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.15 TRADE ANALYSIS
5.15.1 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 16 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
5.15.2 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 17 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
5.16 INDUSTRY TRENDS
5.16.1 DETECTION OF HIV WITH LATERAL FLOW ASSAYS
TABLE 18 US: HIV PREVALENCE RATE, 2016–2021
5.16.2 INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS
5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
5.17.2 BUYING CRITERIA
FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
5.18 LATERAL FLOW ASSAYS MARKET: IMPACT OF INFLATION AND RECESSION
5.19 ARTIFICIAL INTELLIGENCE (AI) IN LATERAL FLOW ASSAY MARKET
TABLE 20 POTENTIAL APPLICATIONS OF AI IN LATERAL FLOW ASSAYS
5.20 UNMET NEEDS/END-USER EXPECTATIONS
TABLE 21 LATERAL FLOW ASSAYS MARKET: UNMET NEEDS/END-USER EXPECTATIONS
5.21 INVESTMENT/VENTURE CAPITAL
FIGURE 35 LATERAL FLOW ASSAYS MARKET: INVESTMENT/VENTURE CAPITAL SCENARIO, 2018–2022
6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 22 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
6.2 KITS & REAGENTS
6.2.1 RISING DEMAND FOR POC TESTING TO DRIVE MARKET
TABLE 23 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
6.3 READERS
TABLE 24 LATERAL FLOW READERS OFFERED, BY COMPANY
TABLE 25 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS
TABLE 26 LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 27 LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
6.3.1 DIGITAL/HANDHELD READERS
6.3.1.1 Technological evolutions and accuracy to drive adoption
TABLE 28 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION).
6.3.2 BENCHTOP READERS
6.3.2.1 Lower diagnosis cost per patient to drive adoption
TABLE 29 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
6.3.3 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW ASSAY READERS
6.3.4 LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE
TABLE 30 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS
FIGURE 36 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2022)
7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 31 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
7.2 CLINICAL TESTING
TABLE 32 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 33 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1 INFECTIOUS DISEASE TESTING
TABLE 34 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 35 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.1 Mosquito-borne diseases
7.2.1.1.1 Increasing incidence of dengue to drive market
TABLE 36 MAJOR PRODUCTS: DENGUE TESTING
TABLE 37 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.2 COVID-19
7.2.1.2.1 Demand for testing to drive market for COVID-19 assays
FIGURE 37 NORTH MARKET SIZING FOR COVID-19: SCENARIO-BASED FORECASTING
TABLE 38 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS
TABLE 39 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.3 Influenza
7.2.1.3.1 Rising prevalence of influenza globally to boost market growth
TABLE 40 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4 Sexually transmitted infections
TABLE 41 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 42 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4.1 HIV
TABLE 43 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4.2 HPV
TABLE 44 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4.3 Chlamydia
TABLE 45 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2021–2029
7.2.1.4.4 Gonorrhea
TABLE 46 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4.5 Syphilis
TABLE 47 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4.6 Other sexually transmitted infections
TABLE 48 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.5 Hepatitis
7.2.1.5.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing
TABLE 49 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.6 Tuberculosis
7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment to drive market
TABLE 50 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.7 Other infectious diseases
TABLE 51 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2 CARDIAC MARKER TESTING
TABLE 52 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 53 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.1 Troponin I & T
7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive market
TABLE 54 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.2 CK-MB
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market
TABLE 55 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.3 BNP & NT-proBNP
7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth
TABLE 56 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.4 Myoglobin
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth
TABLE 57 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.5 D-Dimer
7.2.2.5.1 Rising incidence of CVDs to drive market for D-dimer tests
TABLE 58 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.6 Other cardiac marker tests
TABLE 59 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.3 PREGNANCY & FERTILITY TESTING
TABLE 60 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 61 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.3.1 Pregnancy testing
7.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth
TABLE 62 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.3.2 Fertility testing
7.2.3.2.1 Rising infertility rates to drive demand for POC fertility testing kits
TABLE 63 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.4 CHOLESTEROL/LIPID TESTING
7.2.4.1 Lifestyle changes, rising obesity prevalence to drive market
TABLE 64 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.5 DRUGS-OF-ABUSE TESTING
7.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market
TABLE 65 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.6 OTHER CLINICAL TESTS
TABLE 66 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2021–2029 (USD MILLION)
7.3 VETERINARY DIAGNOSTICS
7.3.1 INFECTIOUS DISEASE OUTBREAKS TO DRIVE MARKET
TABLE 67 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2021–2029 (USD MILLION)
7.4 FOOD SAFETY & ENVIRONMENT TESTING
7.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS
TABLE 68 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.5 DRUG DEVELOPMENT & QUALITY TESTING
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH
TABLE 69 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
8 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE
8.1 INTRODUCTION
TABLE 70 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
8.2 SANDWICH ASSAYS
8.2.1 WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
TABLE 71 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
8.3 COMPETITIVE ASSAYS
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH
TABLE 72 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
8.4 MULTIPLEX DETECTION ASSAYS
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET
TABLE 73 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
9 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE
9.1 INTRODUCTION
TABLE 74 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
9.2 BLOOD SAMPLES
9.2.1 INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET
TABLE 75 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
9.3 URINE SAMPLES
9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET
TABLE 76 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
9.4 SALIVA SAMPLES
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
TABLE 77 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
9.5 OTHER SAMPLES
TABLE 78 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
10 LATERAL FLOW ASSAYS MARKET, BY END USER
10.1 INTRODUCTION
TABLE 79 LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.2 HOSPITALS & CLINICS
10.2.1 INCREASING USE OF POC TESTS TO DRIVE MARKET
TABLE 80 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2029 (USD MILLION)
10.3 HOME CARE SETTINGS
10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
TABLE 81 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2029 (USD MILLION)
10.4 DIAGNOSTIC LABORATORIES
10.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
TABLE 82 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2029 (USD MILLION)
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
TABLE 83 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2029 (USD MILLION)
10.6 OTHER END USERS
TABLE 84 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2029 (USD MILLION)
11 LATERAL FLOW ASSAYS MARKET, BY REGION
11.1 INTRODUCTION
FIGURE 38 CHINA TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD
TABLE 85 LATERAL FLOW ASSAYS MARKET, BY REGION, 2021–2029 (USD MILLION)
11.2 NORTH AMERICA
TABLE 86 NORTH AMERICA: MACROECONOMIC INDICATORS
FIGURE 39 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
TABLE 87 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 89 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 93 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 98 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.2.1 NORTH AMERICA: RECESSION IMPACT
11.2.2 US
11.2.2.1 US to hold largest market share of global market, by country
TABLE 99 US: MACROECONOMIC INDICATORS
TABLE 100 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 101 US: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 102 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 103 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 104 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 105 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 106 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 107 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 108 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 109 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 110 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029USD MILLION)
11.2.3 CANADA
11.2.3.1 Availability of research funding and implementation of favorable government initiatives to drive market
TABLE 111 CANADA: MACROECONOMIC INDICATORS
TABLE 112 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 113 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 114 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 115 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 116 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 117 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 118 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 119 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 120 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 121 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 122 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: RECESSION IMPACT
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 125 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 126 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 127 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 128 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 130 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 131 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 132 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 133 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 134 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Growing number of POC diagnostics centers to drive demand
TABLE 135 GERMANY: MACROECONOMIC INDICATORS
TABLE 136 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 137 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 138 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 139 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 140 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 141 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 142 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 143 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 144 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 145 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 146 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 High prevalence of age-related chronic diseases and infectious diseases to drive market
TABLE 147 FRANCE: MACROECONOMIC INDICATORS
TABLE 148 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 149 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 150 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 151 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 152 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 153 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 154 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 155 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 156 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 157 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 158 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.4 UK
11.3.4.1 Rising prevalence of obesity to propel market
TABLE 159 UK: MACROECONOMIC INDICATORS
TABLE 160 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 161 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 162 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 163 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 164 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 165 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 166 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 167 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 168 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 169 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 170 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Growing initiatives toward decentralization of medical services to support market growth
TABLE 171 ITALY: MACROECONOMIC INDICATORS
TABLE 172 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 173 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 174 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 175 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 176 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 177 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 178 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 179 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 180 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 181 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 182 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Increasing focus of international organizations and domestic players on developing POC products to aid market growth
TABLE 183 SPAIN: MACROECONOMIC INDICATORS
TABLE 184 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 185 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 186 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 187 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 188 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 189 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 190 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 191 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 192 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 193 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 194 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 195 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 196 REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 197 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 198 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 199 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 200 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 201 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 202 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 203 REST OF EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 204 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 205 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION
1.3.2 REGIONS COVERED
FIGURE 2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Breakdown of primaries
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
FIGURE 7 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2022)
FIGURE 8 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2022)
FIGURE 9 APPROACH 4: TOP-DOWN APPROACH
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2029): IMPACT ON MARKET GROWTH AND CAGR
FIGURE 11 CAGR PROJECTIONS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 12 DATA TRIANGULATION METHODOLOGY
2.4 KEY INDUSTRY INSIGHTS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
2.7 STUDY ASSUMPTIONS
2.8 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION)
FIGURE 14 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023 VS. 2029 (USD MILLION)
FIGURE 15 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
FIGURE 16 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023 VS. 2029 (USD MILLION)
FIGURE 17 LATERAL FLOW ASSAYS MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
FIGURE 18 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
FIGURE 19 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET
FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD
4.3 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY (2022)
FIGURE 21 CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
4.5 LATERAL FLOW ASSAYS MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES
FIGURE 23 EMERGING ECONOMIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 High prevalence of infectious diseases
TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021)
5.2.1.2 Rising geriatric population
FIGURE 25 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION)
FIGURE 26 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION)
5.2.1.3 Growing use of home-based lateral flow assay devices
5.2.1.4 Growing demand for POC testing
5.2.2 RESTRAINTS
5.2.2.1 Inconsistent results of lateral flow assay tests
5.2.3 OPPORTUNITIES
5.2.3.1 Evolving applications of lateral flow assays
TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
5.2.3.2 Rising demand for lateral flow assays in food & beverage industry
5.2.3.3 Emergence of Omicron COVID variant
TABLE 4 EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT
TABLE 5 EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE TO DETECT OMICRON
5.2.4 CHALLENGES
5.2.4.1 Limited reimbursements for lateral flow assay products
5.2.4.2 Difficulties in procuring quality raw materials to develop tests
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND, BY APPLICATION
TABLE 6 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY COMPANY AND APPLICATION, 2021–2023
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
TABLE 7 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 2022
5.5 ECOSYSTEM
TABLE 8 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS (2022)
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL & MEDIUM-SIZED COMPANIES
5.6.3 END USERS
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN LATERAL FLOW ASSAYS MARKET, 2013–2023
5.7.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS
FIGURE 29 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016–2022
5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016–2022
5.8 VALUE CHAIN ANALYSIS
FIGURE 31 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2022)
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS
5.9.2 ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
5.10 CASE STUDY ANALYSIS
5.10.1 CASE STUDY 1: QUIDEL LAUNCHES NEW TEST WITH BROADER DETECTION WINDOW
5.10.2 CASE STUDY 2: ABINGTON OFFERS HIGH-SENSITIVITY TESTS FOR GREATER QUALITY
5.10.3 CASE STUDY 3: SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY LANDSCAPE
5.11.1.1 North America
5.11.1.2 Europe
5.11.1.3 Asia
5.11.1.3.1 India
5.11.1.3.2 China
5.11.1.3.3 Japan
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.1 North America
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.2 Europe
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.3 Asia Pacific
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.4 Latin America
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2.5 Rest of the world
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 14 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 ADJACENT MARKET ANALYSIS
FIGURE 32 LATERAL FLOW ASSAYS: OVERVIEW OF ADJACENT MARKETS
5.14 KEY CONFERENCES AND EVENTS, 2023–2024
TABLE 15 LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.15 TRADE ANALYSIS
5.15.1 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 16 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
5.15.2 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 17 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
5.16 INDUSTRY TRENDS
5.16.1 DETECTION OF HIV WITH LATERAL FLOW ASSAYS
TABLE 18 US: HIV PREVALENCE RATE, 2016–2021
5.16.2 INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS
5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
5.17.2 BUYING CRITERIA
FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
5.18 LATERAL FLOW ASSAYS MARKET: IMPACT OF INFLATION AND RECESSION
5.19 ARTIFICIAL INTELLIGENCE (AI) IN LATERAL FLOW ASSAY MARKET
TABLE 20 POTENTIAL APPLICATIONS OF AI IN LATERAL FLOW ASSAYS
5.20 UNMET NEEDS/END-USER EXPECTATIONS
TABLE 21 LATERAL FLOW ASSAYS MARKET: UNMET NEEDS/END-USER EXPECTATIONS
5.21 INVESTMENT/VENTURE CAPITAL
FIGURE 35 LATERAL FLOW ASSAYS MARKET: INVESTMENT/VENTURE CAPITAL SCENARIO, 2018–2022
6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 22 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
6.2 KITS & REAGENTS
6.2.1 RISING DEMAND FOR POC TESTING TO DRIVE MARKET
TABLE 23 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
6.3 READERS
TABLE 24 LATERAL FLOW READERS OFFERED, BY COMPANY
TABLE 25 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS
TABLE 26 LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 27 LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
6.3.1 DIGITAL/HANDHELD READERS
6.3.1.1 Technological evolutions and accuracy to drive adoption
TABLE 28 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION).
6.3.2 BENCHTOP READERS
6.3.2.1 Lower diagnosis cost per patient to drive adoption
TABLE 29 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
6.3.3 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW ASSAY READERS
6.3.4 LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE
TABLE 30 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS
FIGURE 36 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2022)
7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 31 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
7.2 CLINICAL TESTING
TABLE 32 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 33 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1 INFECTIOUS DISEASE TESTING
TABLE 34 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 35 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.1 Mosquito-borne diseases
7.2.1.1.1 Increasing incidence of dengue to drive market
TABLE 36 MAJOR PRODUCTS: DENGUE TESTING
TABLE 37 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.2 COVID-19
7.2.1.2.1 Demand for testing to drive market for COVID-19 assays
FIGURE 37 NORTH MARKET SIZING FOR COVID-19: SCENARIO-BASED FORECASTING
TABLE 38 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS
TABLE 39 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.3 Influenza
7.2.1.3.1 Rising prevalence of influenza globally to boost market growth
TABLE 40 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4 Sexually transmitted infections
TABLE 41 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 42 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4.1 HIV
TABLE 43 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4.2 HPV
TABLE 44 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4.3 Chlamydia
TABLE 45 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2021–2029
7.2.1.4.4 Gonorrhea
TABLE 46 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4.5 Syphilis
TABLE 47 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.4.6 Other sexually transmitted infections
TABLE 48 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.5 Hepatitis
7.2.1.5.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing
TABLE 49 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.6 Tuberculosis
7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment to drive market
TABLE 50 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.7 Other infectious diseases
TABLE 51 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2 CARDIAC MARKER TESTING
TABLE 52 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 53 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.1 Troponin I & T
7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive market
TABLE 54 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.2 CK-MB
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market
TABLE 55 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.3 BNP & NT-proBNP
7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth
TABLE 56 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.4 Myoglobin
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth
TABLE 57 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.5 D-Dimer
7.2.2.5.1 Rising incidence of CVDs to drive market for D-dimer tests
TABLE 58 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.2.6 Other cardiac marker tests
TABLE 59 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.3 PREGNANCY & FERTILITY TESTING
TABLE 60 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 61 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.3.1 Pregnancy testing
7.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth
TABLE 62 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.3.2 Fertility testing
7.2.3.2.1 Rising infertility rates to drive demand for POC fertility testing kits
TABLE 63 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.4 CHOLESTEROL/LIPID TESTING
7.2.4.1 Lifestyle changes, rising obesity prevalence to drive market
TABLE 64 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.5 DRUGS-OF-ABUSE TESTING
7.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market
TABLE 65 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.6 OTHER CLINICAL TESTS
TABLE 66 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2021–2029 (USD MILLION)
7.3 VETERINARY DIAGNOSTICS
7.3.1 INFECTIOUS DISEASE OUTBREAKS TO DRIVE MARKET
TABLE 67 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2021–2029 (USD MILLION)
7.4 FOOD SAFETY & ENVIRONMENT TESTING
7.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS
TABLE 68 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
7.5 DRUG DEVELOPMENT & QUALITY TESTING
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH
TABLE 69 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
8 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE
8.1 INTRODUCTION
TABLE 70 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
8.2 SANDWICH ASSAYS
8.2.1 WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
TABLE 71 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
8.3 COMPETITIVE ASSAYS
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH
TABLE 72 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
8.4 MULTIPLEX DETECTION ASSAYS
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET
TABLE 73 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
9 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE
9.1 INTRODUCTION
TABLE 74 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
9.2 BLOOD SAMPLES
9.2.1 INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET
TABLE 75 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
9.3 URINE SAMPLES
9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET
TABLE 76 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
9.4 SALIVA SAMPLES
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
TABLE 77 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
9.5 OTHER SAMPLES
TABLE 78 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
10 LATERAL FLOW ASSAYS MARKET, BY END USER
10.1 INTRODUCTION
TABLE 79 LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
10.2 HOSPITALS & CLINICS
10.2.1 INCREASING USE OF POC TESTS TO DRIVE MARKET
TABLE 80 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2029 (USD MILLION)
10.3 HOME CARE SETTINGS
10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
TABLE 81 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2029 (USD MILLION)
10.4 DIAGNOSTIC LABORATORIES
10.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
TABLE 82 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2029 (USD MILLION)
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
TABLE 83 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2029 (USD MILLION)
10.6 OTHER END USERS
TABLE 84 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2029 (USD MILLION)
11 LATERAL FLOW ASSAYS MARKET, BY REGION
11.1 INTRODUCTION
FIGURE 38 CHINA TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD
TABLE 85 LATERAL FLOW ASSAYS MARKET, BY REGION, 2021–2029 (USD MILLION)
11.2 NORTH AMERICA
TABLE 86 NORTH AMERICA: MACROECONOMIC INDICATORS
FIGURE 39 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
TABLE 87 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 89 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 93 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 98 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.2.1 NORTH AMERICA: RECESSION IMPACT
11.2.2 US
11.2.2.1 US to hold largest market share of global market, by country
TABLE 99 US: MACROECONOMIC INDICATORS
TABLE 100 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 101 US: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 102 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 103 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 104 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 105 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 106 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 107 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 108 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 109 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 110 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029USD MILLION)
11.2.3 CANADA
11.2.3.1 Availability of research funding and implementation of favorable government initiatives to drive market
TABLE 111 CANADA: MACROECONOMIC INDICATORS
TABLE 112 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 113 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 114 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 115 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 116 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 117 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 118 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 119 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 120 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 121 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 122 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: RECESSION IMPACT
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 125 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 126 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 127 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 128 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 130 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 131 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 132 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 133 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 134 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Growing number of POC diagnostics centers to drive demand
TABLE 135 GERMANY: MACROECONOMIC INDICATORS
TABLE 136 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 137 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 138 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 139 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 140 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 141 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 142 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 143 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 144 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 145 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 146 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 High prevalence of age-related chronic diseases and infectious diseases to drive market
TABLE 147 FRANCE: MACROECONOMIC INDICATORS
TABLE 148 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 149 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 150 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 151 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 152 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 153 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 154 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 155 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 156 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 157 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 158 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.4 UK
11.3.4.1 Rising prevalence of obesity to propel market
TABLE 159 UK: MACROECONOMIC INDICATORS
TABLE 160 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 161 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 162 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 163 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 164 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 165 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 166 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 167 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 168 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 169 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 170 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Growing initiatives toward decentralization of medical services to support market growth
TABLE 171 ITALY: MACROECONOMIC INDICATORS
TABLE 172 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 173 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 174 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 175 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 176 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 177 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 178 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 179 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 180 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 181 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 182 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Increasing focus of international organizations and domestic players on developing POC products to aid market growth
TABLE 183 SPAIN: MACROECONOMIC INDICATORS
TABLE 184 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 185 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 186 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 187 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 188 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 189 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 190 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 191 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 192 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 193 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 194 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 195 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
TABLE 196 REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 197 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
TABLE 198 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 199 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
TABLE 200 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
TABLE 201 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 202 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
TABLE 203 REST OF EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
TABLE 204 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
TABLE 205 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
